Weakness in Losartan potassium - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Weakness, when it was recovered, drug effectiveness, race, and more among people who take Losartan potassium (losartan potassium). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Losartan potassium?

Losartan potassium has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 51,513 Losartan potassium users. Check the latest studies of Losartan potassium.

What is Weakness?

Weakness is found to be associated with 3,639 drugs and 6,616 conditions by eHealthMe. Check the latest studies of Weakness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 03, 2026

84 people who have Weakness while taking Losartan potassium were studied.

Could Losartan potassium cause Weakness?

Severity of Weakness *:

least: 6.76 %
moderate: 60.81 %
severe: 29.73 %
most severe: 2.7 %

When people recovered from Weakness *:

while on drug: 6.67 %
after off the drug: 4.44 %
not yet: 88.89 %

Effectiveness of Losartan potassium *:

not at all: 1.82 %
somewhat: 21.82 %
moderate: 38.18 %
high: 29.09 %
very high: 9.09 %

Race of the people *:

African American, Non-Hispanic: 4.35 %
American Indian/Alaska Native: 0.0 %
Asian: 4.35 %
Hispanic: 5.8 %
Native Hawaiians/Pacific Islanders: 0.0 %
Two or more races: 0.0 %
White, Non-Hispanic: 85.51 %

Time on Losartan potassium *:

Gender of people when taking Losartan potassium *:

female: 47.62 %
male: 52.38 %

Age of people when taking Losartan potassium *:

Conditions people have *:

High Blood Cholesterol: 32 people, 38.10%
Diabetes: 12 people, 14.29%
Depression: 12 people, 14.29%
Stress And Anxiety: 11 people, 13.10%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 9 people, 10.71%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 10.71%
Insomnia (sleeplessness): 6 people, 7.14%
Heart Failure: 5 people, 5.95%
Pain: 5 people, 5.95%
Peripheral Neuropathy (damage to nerves of the peripheral nervous system): 4 people, 4.76%

Other drugs people take besides Losartan potassium *:

Other side effects people have besides Weakness *:

Fatigue (feeling of tiredness): 23 people, 27.38%
Dizziness: 18 people, 21.43%
Stress And Anxiety: 6 people, 7.14%
Nausea (feeling of having an urge to vomit): 6 people, 7.14%
Headache (pain in head): 5 people, 5.95%
Joint Pain: 5 people, 5.95%
Depression: 4 people, 4.76%
Confusion: 4 people, 4.76%
Numbness And Tingling (unusual prickling sensations): 4 people, 4.76%
Insomnia (sleeplessness): 4 people, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Losartan potassium and have Weakness?

Check whether Weakness is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Weakness in Losartan potassium

How the study uses the data?

The study is based on losartan potassium (the active ingredients of Losartan potassium). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.